Pioneering collaboration advances nuclear medicine
This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.
Showing 1 - 20 of 62 results
This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.
ANSTO’s Innovation Precinct welcomes NSW Government’s $12.5 commitment funding.
Bushfires in proximity to ANSTO during the 2018 bushfires.
Australia’s new state-of-the-art nuclear medicine facility gets green light.
Do you love science? Here is a competition for you that combines chemistry and creativity! Discover the world of elements and create a poster for your favourite element in this new competition for school aged students.
See details of previously published customer updates from our Health products team.
ANSTO to receive a new grant to continue to fight chronic kidney disease killer in Sri Lanka.
ANSTO offers a broad range of programs and services to various industries and customers. Many of these services, including the Australian Nuclear Medicine Traceability program, are supported by online customer portals.
The Biological Small Angle X-ray Scattering beamline will be optimised for measuring small angle scattering of surfactants, nanoparticles, polymers, lipids, proteins and other biological macromolecules in solution. BioSAXS combines combine a state-of-the-art high-flux small angle scattering beamline with specialised in-line protein purification and preparation techniques for high-throughput protein analysis.